-       Report 
   - October 2025
    -  184 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                  -       Report 
   - October 2025
    -  194 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                -       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - April 2025
    -  175 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - September 2025
    -  101 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                   -       Report 
   - February 2021
    -  420 Pages 
    United States
   
   From       €1726EUR$1,920USD£1,513GBP 
      €2157EUR$2,400USD£1,892GBP 
                -       Report 
   - September 2021
    -  40 Pages 
    China
   
   From       €2337EUR$2,600USD£2,049GBP 
                  -       Report 
   - July 2023
    -  129 Pages 
    Global
   
   From       €5393EUR$6,000USD£4,730GBP 
      €6741EUR$7,500USD£5,912GBP 
                  -       Report 
   - May 2024
    -  131 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                  -       Report 
   - May 2024
    -  129 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                  -       Report 
   - May 2024
    -  138 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                -       Report 
   - December 2023
    -  117 Pages 
    Global
   
   From       €13478EUR$14,995USD£11,820GBP 
                -       Report 
   - February 2024
    -  75 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
               
         Escitalopram is a selective serotonin reuptake inhibitor (SSRI) used to treat mental disorders such as depression, anxiety, and obsessive-compulsive disorder (OCD). It is the S-enantiomer of the racemic drug citalopram, and is marketed under the brand names Lexapro and Cipralex. Escitalopram is generally well tolerated and has fewer side effects than other SSRIs. It is also used off-label to treat premenstrual dysphoric disorder, panic disorder, and social anxiety disorder.
The escitalopram market    is highly competitive, with several major players offering generic and branded versions of the drug. Companies such as Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals are among the leading manufacturers of generic escitalopram. Branded versions of the drug are marketed by Forest Laboratories, Lundbeck, and H. Lundbeck A/S. Show Less   Read more